Sanofi CEO courts controversy after saying US is first in line for COVID-19 vaccine

Sanofi’s CEO Paul Hudson has courted controversy by saying the French pharma’s potential COVID-19 vaccine will likely be delivered to the US government first should it succeed in clinical trials.